Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool July 1, 2011 Dan Radovsky	Can the Human Genetics Industry Survive the Courts? The future of gene patents is at stake.
The Motley Fool October 3, 2007 Rich Duprey	No Patents on Thinking ... Yet Over the years, the U.S. Patent office has patented a few too many ideas. The Supreme Court is now spending more time deciding whether a company has really infringed on a patent, rather than automatically issuing an infringement.
Chemistry World April 3, 2008 Rebecca Trager	GSK Challenge to US Patent Rules Successful A US district court has said that the US patent office cannot introduce new rules that drug firms argued were a threat to innovation.
IEEE Spectrum June 2012 Kirk Teska	The Patent Eligibility Bar Gets Raised Again Yet, for the fourth time in 150 years, the Supreme Court fails to clearly distinguish between an invention and an idea
Information Today July 6, 2010 George H. Pike	Supreme Court Confirms Patentability of Business Methods, Denies Bilski Patent The lengthy and complex decision, entitled Bilski v. Kappos, affirmed the legality of business method patents, while leaving unanswered some questions about the scope and breadth of such patents.
IEEE Spectrum March 2009 Steven J. Frank	The Death of Business-Method Patents From now on, you can get a U.S. patent only on a mousetrap -- not on the idea of catching mice
Bio-IT World November 12, 2002 Andrew W. Torrance	After the Gene Rush About 20,000 gene-related patents have been granted in the U.S. so far, with twice as many on the way. The practical and political challenges are equally large.
Bank Systems & Technology June 29, 2010 Matt Gunn	Supreme Court Rejects Business Method Patent Ruling in Bilski v. Kappos doesn't shut door on business method patents, but doesn't clarify them either.
BusinessWeek May 14, 2007 Michael Orey	A Higher Hurdle For Inventors Has it become too easy to win and defend patents? The Supreme Court says yes.
InternetNews March 16, 2004 Susan Kuchinskas	Patently Unfair? Overworked patent examiners and outdated rules are just two of the reasons critics of some tech patents say the process needs fixing.
Entrepreneur September 2006 Jane Easter Bahls	Toppling Trolls Patent trolls take a hit in a Supreme Court ruling.
The Motley Fool March 31, 2010 Brian Orelli	When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies.
Chemistry World April 8, 2013 Sarah Houlton	India rejects Novartis patent appeal India's Supreme Court has denied Novartis' appeal against the decision to refuse patent protection for its anticancer drug Glivec (imatinib mesylate).
Chemistry World January 7, 2015 Rebecca Trager	Myriad loses appeal on cancer gene test patents Myriad Genetics has lost its appeal over patents on the BRCA genes that are associated with a higher risk of breast and ovarian cancer.
Inc. June 2006 Athena Schindelheim	Great Moments In Patent History With the blockbuster BlackBerry settlement and a case involving eBay before the Supreme Court, the dowdy world of patent law is suddenly hot.
InternetNews July 31, 2007 Larry Barrett	RealNetworks Case Highlights Sea-Change In Patent Law Supreme Court ruling puts patent trolls on notice.
Pharmaceutical Executive August 1, 2005 Jill Wechsler	Washington Report: Treating Patents It may seem unusual that a court ruling challenging patent protections is considered a victory for Big Pharma. But the decision was supported by pharmaceutical companies, along with the Justice Department, as a way to spur biomedical research and new-drug development.
CFO May 1, 2008 Marie Leone	Patents under Pressure The battle over business-method patents heads to court in what may be a landmark decision.
IEEE Spectrum October 2008 Wayne P. Sobon	Opinion: The Federal Circuit Must Uphold Patent Protection for Business Methods The decision in the Bilski case will have major implications for business method patents
IEEE Spectrum November 2008 Kirk Teska	Commentary: Business-Method Patents--Down But Not Out? The Bilski case leaves us with more questions than answers
The Motley Fool June 15, 2005 Brian Gorman	Patented Drugs Fair Game in R&D The Supreme Court's ruling could be bad news for investors in small pharma and biotech.
InternetNews February 16, 2007 Roy Mark	Patent Reform: Beware of Unintended Consequences Is it fair to patent software?
InternetNews April 30, 2007 Roy Mark	Supreme Court Sides With Microsoft Judges dismiss AT&T claim that overseas sales of Windows are subject to U.S. patent laws.
Chemistry World November 2, 2007 Rebecca Trager	GSK Blocks US Patent Law Changes Pharmaceutical giant GlaxoSmithKline (GSK) has temporarily blocked the US Patent and Trademark Office from implementing new rules, which it fears could prevent innovators from obtaining adequate patent coverage on their inventions.
Chemistry World June 20, 2013 Sarah Houlton	US supreme court rules genes can't be patented In a long-running case against Myriad Genetics, the court decided the BRCA1 and BRCA2 genes are a 'product of nature, and not patent eligible merely because [they have] been isolated.'
InternetNews May 10, 2007 Roy Mark	Vonage Playing Supreme Court Card Vonage claims a recent Supreme Court ruling will make it obvious company didn't infringe on Verizon patents.
InternetNews February 23, 2007 Roy Mark	Supreme Doubts on Software Patents In Microsoft v. AT&T, justices went digging for answers about software patents even though the issue wasn't in play.
Chemistry World March 3, 2015 Rebecca Trager	US universities warn against patent reform proposals Legislation pending in the US Congress to address so-called patent trolling is crafted too broadly and would damage the flow of discoveries from academia to the private sector.
IEEE Spectrum October 2007 Kirk Teska	How High Is the Patent Bar Now? Has the Supreme Court's ruling eviscerated the patents for hosts of products -- even Apple's iPod?
The Motley Fool August 31, 2011 John Grgurich	How the Patent Wars Are Hurting High-Tech Well-intentioned patent laws are threatening to stifle innovation.
CIO January 1, 2003 Christopher Koch	Patently Stupid? It's not clear at the start of 2003 whether the software patent frenzy will cause innovation to flower or be trampled.
BusinessWeek January 9, 2006 Lorraine Woellert	A Docket Packed with Patent Feuds Three key cases will shape a vast swath of the business landscape. At issue: Products, services, even ideas - and whether your BlackBerry stays connected.
IEEE Spectrum March 2006 Kirk Teska	The Story Behind the BlackBerry Case A single filing with the U.S. Patent and Trademark Office in 1991 has caused one of the largest patent disputes in recent memory, threatening to sever more than 3 million BlackBerry subscribers from their wireless e-mail service.
InternetNews April 18, 2007 Roy Mark	Dems, Republicans Unite on Patent Reform Identical bills introduced in House and Senate to reduce infringement awards and to change Patent Office procedures.
The Motley Fool March 13, 2008 Stephen Albainy-Jenei	Pfizer's Celebrex Aches and Pains The Court of Appeals for the Federal Circuit upholds a lower court's ruling that found Teva Pharmaceutical had infringed two of Pfizer's patents for Celebrex.
Chemistry World May 22, 2013 Rebecca Trager	US Supreme Court rules in favour of Monsanto The Supreme Court justices upheld a lower court's ruling that a farmer, Vernon Bowman, violated Monsanto's intellectual property rights by regrowing second-generation seeds.
Knowledge@Wharton	Drug Companies and the Patent Game: Fair Play or Foul? Is legal maneuvering a legitimate attempt by the big pharmaceutical companies to recover the huge costs of developing new drugs? Or are the brand-name firms inappropriately gaming the system for their own benefit, to the detriment of consumers and insurance companies?
BusinessWeek January 9, 2006 Michael Orey	The Patent Epidemic Overpatenting is wasting companies' money and slowing the development of new products.
InternetNews June 9, 2011	Microsoft Loses Supreme Court Patent Case Top U.S. court rules against Microsoft in i4i patent appeal.
InternetNews January 30, 2007 Roy Mark	Second Look For Dynamic Web Patents The U.S. Patent and Trademark Office will review two patents held by EpicRealm, a Texas firm that has filed a number of infringement lawsuits against companies employing dynamic Web technology.
Pharmaceutical Executive March 1, 2013 Henninger & Feldstein	Safeguarding the Value of Patent Assets As small biotech firms test the water in partnerships with Big Pharma, the best calling card is a well-framed strategy on intellectual property.
InternetNews November 28, 2006 Roy Mark	High Court Tackles The Not-So-Obvious The United States Supreme Court will talk gas pedals today in a case the technology industry hopes the justices will find all too obvious. The outcome could be a landmark decision that redefines how patents are issued.
Information Today September 15, 2011 George H. Pike	Congress Enacts Patent Reform Legislation In what is being described as the most substantial overhaul of U.S. patent law in nearly 60 years, Congress passed the Leahy-Smith America Invents Act, patent reform legislation that has been years in the making.
CIO August 1, 2003 Lawrence Rosen	Patents: An Expensive Tax on the CIO Software patents cost you money. Like taxes, they skim from your profit margins, but in this case the fees go to pay for other companies' intellectual property.
Information Today October 16, 2006 K. Matthew Dames	The Patent System on Tilt: IBM Seeks to Change the Game IBM wants to change the way the patent system works, holding itself out as an exemplar of openness.
Pharmaceutical Executive May 1, 2005 Margaret Buck	Legal: No Exception? An important legal loophole has made patented tools available for biotech research. Today, though, it appears to be closing.
Pharmaceutical Executive August 1, 2011 Jill Wechsler	The Supremes Shape Pharma A number of important decisions from the Supreme Court will affect drug marketing, research, and regulation
IEEE Spectrum July 2005 Ben Klemens	Software Patents Don't Compute How the U.S. patent system attempts to draw a dividing line between patentable machines and unpatentable mathematics- and why the system is failing.
IEEE Spectrum August 2005 Ben Klemens	New Legal Code Copyrights should replace software patents.
Chemistry World January 30, 2015 Rebecca Trager	Myriad calls a ceasefire in court battle over cancer gene tests Myriad Genetics has ended its bid to prevent other companies from producing tests for genetic mutations associated with an increased risk of breast and ovarian cancer that it owned patents on.